000 | 01766 a2200493 4500 | ||
---|---|---|---|
005 | 20250514011016.0 | ||
264 | 0 | _c20011004 | |
008 | 200110s 0 0 eng d | ||
022 | _a0003-4819 | ||
024 | 7 |
_a10.7326/0003-4819-135-6-200109180-00008 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHylek, E M | |
245 | 0 | 0 |
_aClinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin. _h[electronic resource] |
260 |
_bAnnals of internal medicine _cSep 2001 |
||
300 |
_a393-400 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAge Factors |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAnticoagulants _xadministration & dosage |
650 | 0 | 4 |
_aAntifibrinolytic Agents _xtherapeutic use |
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHalf-Life |
650 | 0 | 4 |
_aHeart Failure _xcomplications |
650 | 0 | 4 |
_aHemorrhage _xchemically induced |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInternational Normalized Ratio |
650 | 0 | 4 | _aLogistic Models |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNeoplasms _xcomplications |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aVitamin K 1 _xtherapeutic use |
650 | 0 | 4 |
_aWarfarin _xadministration & dosage |
700 | 1 | _aRegan, S | |
700 | 1 | _aGo, A S | |
700 | 1 | _aHughes, R A | |
700 | 1 | _aSinger, D E | |
700 | 1 | _aSkates, S J | |
773 | 0 |
_tAnnals of internal medicine _gvol. 135 _gno. 6 _gp. 393-400 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.7326/0003-4819-135-6-200109180-00008 _zAvailable from publisher's website |
999 |
_c11482579 _d11482579 |